Bioharvest Sciences IncCanadian Securities Exchange:BHSCView on OTCQB
- LAST PRICE0.2600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.2350/ 6
- Ask / Lots0.2550/ 39
- Open / Previous Close0.0000 / 0.2600
- Day Range---
- 52 Week Range
- Volume1
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | BHSC |
|---|
Yesterday
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity, from 8:03AM ET on Tuesday Apr 16, 2024 by Dow Jones
8:03AM ET on Tuesday Apr 16, 2024 by Dow Jones
Mar 27, 2024
BioHarvest Sciences adds key hires as company looks to ramp up CDMO Services Business Unit, from 11:27AM ET on Wednesday Mar 27, 2024 by Dow Jones
11:27AM ET on Wednesday Mar 27, 2024 by Dow Jones
Mar 21, 2024
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables, from 8:33AM ET on Thursday Mar 21, 2024 by Dow Jones
8:33AM ET on Thursday Mar 21, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Bioharvest Sciences Inc | 143.5M | -10.6x | --- |
Happy Belly Food Group Inc | 42.7M | -16.2x | --- |
Else Nutrition Holdings Inc | 36.2M | -1.9x | --- |
Burcon NutraScience Corp | 27.5M | -3.7x | --- |
Hempalta Corp | 16.1M | -2,785.7x | --- |
Britannia Life Sciences Inc | 11.4M | 6.7x | --- |
Company Information
BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.
Contact Information
- Headquarters
- 1140 - 625 Howe StreetVANCOUVER, BC, Canada V6C 2T6
- Phone
- 604-622-1186
- Fax
- 604-622-1186
Executives
- Chairman of the Board, President
- Zaki Rakib
- Chief Executive Officer
- Ilan Sobel
- Chief Financial Officer
- Alan Rootenberg
- Chief Technology Officer
- Yochi Hagay
- Vice President - Investor Relations, Company Secretary, Director
- David Ryan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $143.5M |
|---|---|
Revenue (TTM) | $14.7M |
Shares Outstanding | 552.1M |
Bioharvest Sciences Inc does not pay a dividend. | |
Beta | 1.56 |
EPS | $-0.02 |
Book Value | $-0.02 |
P/E Ratio | -10.6x |
Price/Sales (TTM) | 9.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -93.94% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
